QC
CCRN icon

Quantedge Capital’s Cross Country Healthcare CCRN Stock Holding History

Quantedge Capital’s Portfolio CCRN Stock Details CCRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-37,291
Closed -$516K – 187
2024
Q2 		$516K Sell
37,291
-176,700
-83% -$2.8M 0.19% 115
2024
Q1 		$4.01M Hold
213,991
– – 1.69% 21
2023
Q4 		$4.84M Buy
213,991
+67,591
+46% +$1.47M 2.37% 13
2023
Q3 		$3.63M Buy
146,400
+59,600
+69% +$1.5M 1.98% 13
2023
Q2 		$2.44M Buy
86,800
+35,300
+69% +$877K 1.08% 31
2023
Q1 		$1.15M Buy
+51,500
New +$1.35M 0.45% 61

Other funds holding CCRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantedge Capital's CCRN Position: Q3 2024 in Review

Quantedge Capital sold out of Cross Country Healthcare (CCRN) in Q3 2024, closing a stake of 37,291 shares — an estimated $516K sold.

Quantedge Capital first reported a position in CCRN in Q1 2023 and held it in 6 quarters. The position peaked at $4.84M in Q4 2023. 180 funds tracked by Wall St. Rank hold CCRN as of Q3 2024.

  • Quantedge Capital reported no remaining Cross Country Healthcare position as of Q3 2024 after selling out during the quarter.
  • Quantedge Capital sold 37,291 Cross Country Healthcare shares in Q3 2024, an estimated $516K.
  • Quantedge Capital first reported a position in Cross Country Healthcare in Q1 2023 and held it in 6 quarters.
  • Quantedge Capital's Cross Country Healthcare position peaked at $4.84M in Q4 2023.
  • 180 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q3 2024.

Based on Quantedge Capital's 13F filing for Q3 2024, filed 13 Nov 2024.